Physician profile
Adeepa D Singh
NPI 1275967598
$7,288.67
in general payments reported to CMS, 2019-2025
23 companies · $381 in 2025
The $381 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,229 · 2020: $336 · 2021: $535 · 2022: $1,536 · 2023: $798 · 2024: $473 · 2025: $381.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,653.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,652.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,828.18 | 2019-2023 | Proclaim |
| Nevro Corp. | $1,815.14 | 2019-2024 | Senza |
| Boston Scientific Corporation | $1,459.83 | 2019-2025 | Intracept |
| Medtronic USA, INC. | $746.03 | 2019 | |
| Mml US, INC. | $346.10 | 2022-2023 | Reactiv8 |
| Abbvie INC. | $218.26 | 2023-2024 | Qulipta, Botox |
| Si-Bone, INC. | $172.19 | 2024 | |
| Bioventus LLC | $145.09 | 2023 | Durolane |
| Medtronic, INC. | $104.44 | 2025 | Intellis Adaptivestim |
| Grt US Holding, INC. | $60.27 | 2021-2022 | |
| Globus Medical, INC. | $59.29 | 2025 | Senza |
| Hikma Pharmaceuticals USA | $57.70 | 2022 | |
| Collegium Pharmaceutical, INC. | $56.07 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $36.57 | 2023 | Relistor |
| Scilex Pharmaceuticals INC. | $33.84 | 2022-2023 | Ztlido |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $28.89 | 2023 | Qutenza |
| Janssen Pharmaceuticals, INC | $20.82 | 2019 | |
| Almatica Pharma LLC | $20.70 | 2022 | |
| Arbor Pharmaceuticals, INC. | $18.71 | 2021 | |
| Stryker Corporation | $18.13 | 2025 | Mild Device Kit |
| Kowa Pharmaceuticals America, INC. | $17.45 | 2022 | |
| Vertos Medical, INC. | $12.62 | 2024 | Mild Device Kit |
| Metacel Pharmaceuticals LLC | $12.35 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adeepa Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.